Antibodies to CD200 and uses thereof in inhibiting immune responses

Details for Australian Patent Application No. 2008279619 (hide)

Owner Alexion Pharmaceuticals, Inc.

Inventors Faas McKnight, Susan; Rother, Russell P.

Agent Shelston IP

Pub. Number AU-A-2008279619

PCT Pub. Number WO2009/014745

Priority 60/962,022 25.07.07 US

Filing date 25 July 2008

Wipo publication date 29 January 2009

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 38/13 (2006.01) Medicinal preparations containing peptides

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

18 February 2010 PCT application entered the National Phase

  PCT publication WO2009/014745 Priority application(s): WO2009/014745

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008279636-Central administration of stable formulations of therapeutic agents for CNS conditions

2008279618-Methods and compositions for treating autoimmune disease